Gazyva (obinutuzumab)
pCPA File Number:
23073
Negotiation Status:
Active Negotiation
Indication(s):
In combination with Venclexta, for the treatment of patients with previously untreated chronic lymphocytic leukemia
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0362-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable